alt-836
mAbexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2009 (NCT00879606)
Timeline
Indications
Mechanism of action
- Coagulation factor IIIINHIBITOR
F3 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- alt-836
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01325558 | Phase 1 | May 1, 2011 | Altor Bioscience |
| NCT00879606 | Phase 2 | Apr 1, 2009 | Altor Bioscience, National Heart, Lung, and Blood Institute (NHLBI) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Altor Bioscience | For profit | 2 | 2 | 2 | 2009 |
| National Heart, Lung, and Blood Institute (NHLBI) | Government | 1 | 0 | 1 | 2009 |
2 organizations
Page 1 / 1